Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579566 · ClinicalTrials.gov registry record
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
A clinical trial of Sarcoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 7
- Study locations
NCT00579566 is a study of Sarcoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3,000 participants, above the 897-participant average among 122 other Sarcoma trials with a reported enrollment target (234% higher). The trial reports 7 study locations across 2 states.
The verdict
NCT00579566, a study of Sarcoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue left over after all needed testing has been done or remove an additional small amount of tissue if you are having a biopsy. We will also take blood samples before and/or after your procedure to measure biochemical factors that may help us predict the behavior of sarcoma.
Conditions Studied
Interventions
- OTHER Specimen protocol
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent and Follow-Up) - Commack
- Memorial Sloan Kettering Westchester (Consent and Followup) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (Consent and Followup) - Rockville Centre
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and Followup) - Middletown
- Memorial Sloan Kettering Bergen (Consent and Follow up) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2002-06 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579566
The ClinicalTrials.gov registry entry for NCT00579566 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 897-participant average among 122 other Sarcoma trials with a reported enrollment target (234% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which Specimen protocol is the first listed.
NCT00579566 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT00579566 about?
NCT00579566 is a clinical study titled "Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma". The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatm...
What is the current status of trial NCT00579566?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2002-06. Estimated completion is 2026-06.
What conditions does trial NCT00579566 study?
This clinical trial studies the following conditions: Sarcoma.
What interventions are being tested in trial NCT00579566?
The interventions under investigation include: Specimen protocol (OTHER).
Who is sponsoring clinical trial NCT00579566?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00579566 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
RECRUITING
-
Palbociclib and Pembrolizumab in Sarcoma
RECRUITING · Phase 1
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
RECRUITING · Phase 1
-
Enhanced Recovery After Surgery in Extremity Sarcoma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.